| Name | Title | Contact Details |
|---|
Harbinger is a commercial electric vehicle (EV) company on a mission to transform an industry starving for innovation. Harbingers best-in-class team of EV, battery, and drivetrain experts have pooled their deep experience to support the growing demand for medium-duty EVs. Leveraging a foundation of proprietary, in-house developed vehicle technologies designed specifically for commercial vehicles, Harbinger is bringing a first-of-its-kind EV platform to market, priced for zero acquisition premium. Harbinger: familiar form, revolutionary foundation.
Autohuset Vestergaard A/S, Personvogne er blandt landets største bilvirksomheder. Vi har autoriseret salg af 11 bilmærker - Volvo, Polestar, Renault, KIA, Ford, Mazda, Dacia, Nissan, Maxus, JAC og BYD. Vi er repræsenteret med 12 filialer - Autohuset Vestergaard beskæftiger cirka 450 medarbejdere og sælger årligt mere end 15.000 nye og brugte biler. Vi er specialister inden for person- og varebiler til private og erhvervsdrivende. Autohuset Vestergaard skræddersyer en løsning, der matcher netop dit behov. Hvad end du ønsker at lease eller eje, så har vi løsningen til dig. Alle vores værksteder er ISO-certificerede og bemandet med top professionelle medarbejdere, der sikrer optimal pleje af din bil, uanset om det gælder service, reparation eller skadearbejde. Hos Autohuset Vestergaard er det vores målsætning, at skabe langsigtede relationer med vores kunder. I vores daglige arbejder bestræber vi os altid på at yde den indsats, der skal til, for at vi opnår yderst tilfredse kunder.
YA Group is an international professional services organization with over 25 years of experience, specializing in forensic consulting, engineering, and risk mitigation. Headquartered in the United States, the company employs more than 700 professionals and operates globally. It has evolved from its origins as a property damage consulting firm and has expanded through strategic acquisitions and organic growth. The firm offers a range of services, including forensic engineering and architecture, planning and construction advisory, and risk mitigation. Their expertise covers evaluations of existing structures, project controls, and comprehensive risk reduction strategies. YA Group serves a diverse clientele, including federal agencies, municipalities, healthcare systems, and educational institutions, emphasizing strong partnerships and a commitment to integrity and professionalism. The company is affiliated with several industry organizations, enhancing its credibility and expertise in the field.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.